• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

In the Literature: microRNA Biomarkers For Early Detection of Childhood Cancers

Article

Research to be presented this week at the National Cancer Research Institute Cancer Conference has identified the expression of specific serum microRNAs in pediatric solid tumors, which could prove useful for early diagnosis.

Newly-identified cancer cell fingerprints in the blood could one day help doctors diagnose a range of children's cancers faster and more accurately, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference next week.

The researchers, from the University of Cambridge and Addenbrooke's Hospital in Cambridge, found unique molecular fingerprints for 11 types of children's tumours, which could be used to develop blood tests to diagnose these cancers.

This may eventually lead to a quicker, more accurate way to diagnose tumours, and could also reduce the need for children to undergo surgery to get a diagnosis one day.

The research was funded by Sparks, the children's medical research charity, and Cancer Research UK.

Link to the report on MedicalXpress: http://bit.ly/1tuDIES

Link to the abstract: http://bit.ly/10jNAHz

Related Videos
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
Glenn Balasky during a video interview
dr joseph alvarnas
dr joseph alvarnas
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.